Table 3.

Safety endpoints following treatment with the FlowTriever System

Safety endpoints	n (%)
48‐h all‐cause mortality	0 (0%)
30‐day all‐cause mortality	1 (0.4%)
48‐h MAE composite	3 (1.2%)
Device‐related death	0 (0%)
Major bleeds (none were intracerebral hemorrhages)	3 (1.2%)
Intraprocedural device‐ or procedure‐related adverse events	0 (0%)
Clinical deterioration	0 (0%)
Device‐related pulmonary vascular injuries	0 (0%)
Device‐related cardiac injuries	0 (0%)
30‐day SAE (device‐related)	0 (0%)

Note: Numbers vary from 247 for 48‐h data to 242 for 30‐day data.

Abbreviations: numbers (n), major adverse events (MAE), serious adverse events (SAE).